Torrent Pharma’s acquisition of JB Chemicals, though expensive at 6.5 times EV to sales, strategically strengthens its domestic branded generics and CDMO presence. Jio Financial’s stock surge lacks fundamental justification, driven more by speculation. The IT sector faces a muted outlook, while Mazagon Dock’s Sri Lankan acquisition holds strategic potential despite high valuation.
Originally published by The Economic Times https://economictimes.indiatimes.com/markets